| |||||||||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Species laboratory mouse Donating Investigator David Williams, Indiana University Description
Mice that are homozygous for the targeted mutation are viable, fertile, and normal in size but exhibit phagocytic immunodeficiency. No endogenous gene product (mRNA or protein) was detected by Northern blot analysis, RT-PCR or Western blot analysis. The Rac proteins are a subclass of the Rho family of GTPases, and are involved in actin cytoskeletal organization in cell movement, cell proliferation, kinase signaling pathways, and in superoxide production in phagocytic cells. Neutrophils and mast cells derived from homozygous mice display abnormal actin-based functions: cytoskeleton remodeling ability, adhesion, migration, degranulation, and phagocytosis. Diminished superoxide production in response to some agonists, and reduced total number of leukocytes and neutrophils in peritoneal exudate is observed. As result of functional deficiencies in neutrophil and mast cell populations, these mutant mice are more vulnerable to invasive infection. Slowed growth of mast cells, accompanying reduction in mast cell number and a significant decrease in growth factor-dependent survival was found to be due to increased cell apoptosis. These mutant mice may be useful in studies of phagocytic immunodeficiency, cellular inflammatory responses, hematopoietic cell regulation, and B cell development and signaling.Development
A targeting vector containing neomycin resistance and herpes simplex virus thymidine kinase genes was used to disrupt exon 1 of the Rac2 gene. The construct was electroporated into 129S6/SvEv derived CCE.1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric animals were crossed to C57BL/6 mice.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Rac2tm1Mddw/Rac2tm1Mddw
involves: 129S/SvEv * C57BL/6
- life span-post-weaning/aging
- increased sensitivity to induced morbidity/mortality (MGI Ref ID J:53362)
- Aspergillus fumigatus-infected mice exhibit increased mortality and decreased survival time compared to similarly treated wild-type mice
- immune system phenotype
- abnormal granulocyte differentiation (MGI Ref ID J:53362)
- mice exhibit a modest excess of mature granulopoiesis in the bone marrow compared to in wild-type mice
- abnormal neutrophil physiology (MGI Ref ID J:53362)
- PMA and NADPH-stimulated bone marrow neutrophils exhibit 23% of normal superoxide production
- however, peritoneal exudate neutrophils exhibit normal superoxide production following thioglycollate stimulation
- TNF-alpha and PMA-stimulated bone marrow neutrophils exhibit a 61% of normal superoxide production
- neutrophil integrin adhesion is decreased compared to wild-type cells
- chemotaxis of bone marrow neutrophils is decreased 4- to 10-fold compared to wild-type cells
- impaired neutrophil migration (MGI Ref ID J:53362)
- spreading of neutrophils over glass cover slips is 76% of that observed in wild-type cells
- decreased T cell proliferation (MGI Ref ID J:119437)
- following anti-CD3 antibody stimulation, T cell proliferation is decreased compared to similarly treated wild-type cells
- CD4+ T cell proliferation in response to anti-CD3 antibodies is decreased 2-fold compared to similarly treated wild-type cells
- however, co-stimulation with anti-CD28 antibodies or the addition of IL2 can partially compensate for reduced proliferation of T cells
- decreased leukocyte cell number (MGI Ref ID J:53362)
- at 4 post-thioglycollate treatment, peritoneal exudates exhibit reduced leukocyte numbers compared to in wild-type mice
- decreased neutrophil cell number (MGI Ref ID J:53362)
- at 4 and 18 hours post-thioglycollate treatment, peritoneal exudates exhibit reduced neutrophils numbers compared to in wild-type mice
- increased leukocyte cell number (MGI Ref ID J:53362)
- 1.9-fold higher than in wild-type mice
- increased neutrophil cell number (MGI Ref ID J:53362)
- mice exhibit a 2.5- to 3-fold increased in neutrophil numbers compared to in wild-type mice
- increased susceptibility to bacterial infection (MGI Ref ID J:53362)
- Aspergillus fumigatus-infected mice exhibit increased mortality and decreased survival time compared to similarly treated wild-type mice
- 4 to 6 days post-infection with A. fumigatus, recovery of viable A. fumigatus in the brain and kidney is increased 9.2 and 5.5 times compared to in similarly treated wild-type mice
- foci of hyphae in the renal parenchyma of A. fumigatus-infected mice are surrounded by an exuberant neutrophil infiltrate unlike in wild-type mice
- hematopoietic system phenotype
- abnormal granulocyte differentiation (MGI Ref ID J:53362)
- mice exhibit a modest excess of mature granulopoiesis in the bone marrow compared to in wild-type mice
- decreased T cell proliferation (MGI Ref ID J:119437)
- following anti-CD3 antibody stimulation, T cell proliferation is decreased compared to similarly treated wild-type cells
- CD4+ T cell proliferation in response to anti-CD3 antibodies is decreased 2-fold compared to similarly treated wild-type cells
- however, co-stimulation with anti-CD28 antibodies or the addition of IL2 can partially compensate for reduced proliferation of T cells
- decreased leukocyte cell number (MGI Ref ID J:53362)
- at 4 post-thioglycollate treatment, peritoneal exudates exhibit reduced leukocyte numbers compared to in wild-type mice
- decreased neutrophil cell number (MGI Ref ID J:53362)
- at 4 and 18 hours post-thioglycollate treatment, peritoneal exudates exhibit reduced neutrophils numbers compared to in wild-type mice
- increased leukocyte cell number (MGI Ref ID J:53362)
- 1.9-fold higher than in wild-type mice
- increased neutrophil cell number (MGI Ref ID J:53362)
- mice exhibit a 2.5- to 3-fold increased in neutrophil numbers compared to in wild-type mice
Rac2tm1Mddw/Rac2tm1Mddw
involves: 129S/SvEv
- homeostasis/metabolism phenotype
- abnormal wound healing (MGI Ref ID J:131305)
- lipid peroxidation, respiratory burst activity of neutrophils, and proliferation of vascular endothelial cells, measured by CD31 staining, at the wound site is decreased compared to in wild-type mice
- delayed wound healing (MGI Ref ID J:131305)
- delayed wound healing is associated with a 3-fold decrease in superoxide production at the wound site and a decrease in peroxide concentration in wound fluid compared to in similarly treated wild-type mice
- cardiovascular system phenotype
- abnormal vascular endothelial cell physiology (MGI Ref ID J:131305)
- proliferation of vascular endothelial cells at a wound site is decreased compared to in wild-type mice
- decreased angiogenesis (MGI Ref ID J:131305)
- proliferation of vascular endothelial cells at a wound site is decreased compared to in wild-type mice
- immune system phenotype
- abnormal neutrophil physiology (MGI Ref ID J:131305)
- respiratory burst activity of neutrophils at a wound site is decreased compared to in wild-type mice
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Rac2tm1Mddw related
Apoptosis Research
Extracellular Modulators
Cancer Research
Genes Regulating Growth and Proliferation
Developmental Biology Research
Defects in Cell Adhesion Molecules
Hematological Research
Immunological Defects
B and T cell deficiency
Mast Cell Deficiency
Immunology and Inflammation Research
Growth Factors/Receptors/Cytokines
Immunodeficiency
B cell deficiency
Immunodeficiency Associated with Other Defects
Inflammation
B and T cell deficiency
Neutrophil defects
Intracellular Signaling Molecules
Lymphoid Tissue Defects
B and T cell deficiency
T Cell Receptor Signaling Defects
B and T cell deficiency
Research Tools
Apoptosis Research
Cancer Research
B cell deficiency
T cell deficiency
production of B cells and antibodies
| Allele Symbol | Rac2tm1Mddw | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Mary C Dinauer and David A Williams | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Rac2tm1Daw; rac2-; | ||
| Mutation Made By | David Williams, Indiana University | ||
| Strain of Origin | 129S/SvEv-Gpi1 | ||
| ES Cell Line Name | CCE/EK.CCE | ||
| ES Cell Line Strain | 129S/SvEv-Gpi1 | ||
| Gene Symbol and Name | Rac2, RAS-related C3 botulinum substrate 2 | ||
| Chromosome | 15 | ||
| Gene Common Name(s) | AI323801; AI452260; EN-7; Gx; HSPC022; MGC105983; expressed sequence AI323801; expressed sequence AI452260; | ||
| Molecular Note | A neomycin resistance cassette replaced a genomic fragment containing exon 1, which encodes the translational initiation site and part of the GTP-binding domain. Northern blot and RT-PCR analysis demonstrated that no transcripts were detectable in totalRNA derived from neutrophils or lymphocytes in homozygous mice. Western blot analysis confirmed an absence of protein produced from this allele in peritoneal exudate cells from homozygous mice. [MGI Ref ID J:53362] | ||
Genotyping Protocols
Rac2tm1Mddw, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Roberts AW; Kim C; Zhen L; Lowe JB; Kapur R; Petryniak B; Spaetti A; Pollock JD; Borneo JB; Bradford GB; Atkinson SJ; Dinauer MC; Williams DA. 1999. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10(2):183-96. [PubMed: 10072071] [MGI Ref ID J:53362]
Cancelas JA; Lee AW; Prabhakar R; Stringer KF; Zheng Y; Williams DA. 2005. Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat Med 11(8):886-91. [PubMed: 16025125] [MGI Ref ID J:110380]
Croker BA; Tarlinton DM; Cluse LA; Tuxen AJ; Light A; Yang FC; Williams DA; Roberts AW. 2002. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J Immunol 168(7):3376-86. [PubMed: 11907095] [MGI Ref ID J:75581]
Filippi MD; Harris CE; Meller J; Gu Y; Zheng Y; Williams DA. 2004. Localization of Rac2 via the C terminus and aspartic acid 150 specifies superoxide generation, actin polarity and chemotaxis in neutrophils. Nat Immunol 5(7):744-51. [PubMed: 15170212] [MGI Ref ID J:91126]
Gu Y; Filippi MD; Cancelas JA; Siefring JE; Williams EP; Jasti AC; Harris CE; Lee AW; Prabhakar R; Atkinson SJ; Kwiatkowski DJ; Williams DA. 2003. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302(5644):445-9. [PubMed: 14564009] [MGI Ref ID J:86814]
Rac2tm1Mddw relatedAbdel-Latif D; Steward M; Macdonald DL; Francis GA; Dinauer MC; Lacy P. 2004. Rac2 is critical for neutrophil primary granule exocytosis. Blood 104(3):832-9. [PubMed: 15073033] [MGI Ref ID J:92258]
Arana E; Vehlow A; Harwood NE; Vigorito E; Henderson R; Turner M; Tybulewicz VL; Batista FD. 2008. Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation. Immunity 28(1):88-99. [PubMed: 18191593] [MGI Ref ID J:131150]
Azim AC; Cao H; Gao X; Joo M; Malik AB; van Breemen RB; Sadikot RT; Park G; Christman JW. 2007. Regulation of cyclooxygenase-2 expression by small GTPase Rac2 in bone marrow macrophages. Am J Physiol Lung Cell Mol Physiol 293(3):L668-73. [PubMed: 17575012] [MGI Ref ID J:128040]
Cancelas JA; Jansen M; Williams DA. 2006. The role of chemokine activation of Rac GTPases in hematopoietic stem cell marrow homing, retention, and peripheral mobilization. Exp Hematol 34(8):976-85. [PubMed: 16863904] [MGI Ref ID J:111908]
Croker BA; Handman E; Hayball JD; Baldwin TM; Voigt V; Cluse LA; Yang FC; Williams DA; Roberts AW. 2002. Rac2-deficient mice display perturbed T-cell distribution and chemotaxis, but only minor abnormalities in T(H)1 responses. Immunol Cell Biol 80(3):231-40. [PubMed: 12067410] [MGI Ref ID J:77489]
Croker BA; Tarlinton DM; Cluse LA; Tuxen AJ; Light A; Yang FC; Williams DA; Roberts AW. 2002. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J Immunol 168(7):3376-86. [PubMed: 11907095] [MGI Ref ID J:75581]
Distasi MR; Case J; Ziegler MA; Dinauer MC; Yoder MC; Haneline LS; Dalsing MC; Miller SJ; Labarrere CA; Murphy MP; Ingram DA; Unthank JL. 2009. Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth. Am J Physiol Heart Circ Physiol 296(3):H877-86. [PubMed: 19151256] [MGI Ref ID J:146529]
Dumont C; Corsoni-Tadrzak A; Ruf S; de Boer J; Williams A; Turner M; Kioussis D; Tybulewicz VL. 2009. Rac GTPases play critical roles in early T-cell development. Blood 113(17):3990-8. [PubMed: 19088377] [MGI Ref ID J:148437]
Fulkerson PC; Zhu H; Williams DA; Zimmermann N; Rothenberg ME. 2005. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. Blood 106(2):436-43. [PubMed: 15802529] [MGI Ref ID J:107462]
Gomez JC; Soltys J; Okano K; Dinauer MC; Doerschuk CM. 2008. The role of Rac2 in regulating neutrophil production in the bone marrow and circulating neutrophil counts. Am J Pathol 173(2):507-17. [PubMed: 18583316] [MGI Ref ID J:138295]
Gu Y; Filippi MD; Cancelas JA; Siefring JE; Williams EP; Jasti AC; Harris CE; Lee AW; Prabhakar R; Atkinson SJ; Kwiatkowski DJ; Williams DA. 2003. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302(5644):445-9. [PubMed: 14564009] [MGI Ref ID J:86814]
Guo F; Cancelas JA; Hildeman D; Williams DA; Zheng Y. 2008. Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development. Blood 112(5):1767-75. [PubMed: 18579797] [MGI Ref ID J:138889]
Hall AB; Gakidis MA; Glogauer M; Wilsbacher JL; Gao S; Swat W; Brugge JS. 2006. Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis. Immunity 24(3):305-16. [PubMed: 16546099] [MGI Ref ID J:113323]
Ingram DA; Hiatt K; King AJ; Fisher L; Shivakumar R; Derstine C; Wenning MJ; Diaz B; Travers JB; Hood A; Marshall M; Williams DA; Clapp DW. 2001. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 194(1):57-69. [PubMed: 11435472] [MGI Ref ID J:71331]
Kalfa TA; Pushkaran S; Mohandas N; Hartwig JH; Fowler VM; Johnson JF; Joiner CH; Williams DA; Zheng Y. 2006. Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood 108(12):3637-45. [PubMed: 16882712] [MGI Ref ID J:140447]
Kim C; Dinauer MC. 2006. Impaired NADPH oxidase activity in Rac2-deficient murine neutrophils does not result from defective translocation of p47phox and p67phox and can be rescued by exogenous arachidonic acid. J Leukoc Biol 79(1):223-34. [PubMed: 16275890] [MGI Ref ID J:104739]
Kim C; Dinauer MC. 2001. Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways. J Immunol 166(2):1223-32. [PubMed: 11145705] [MGI Ref ID J:66852]
Koh AL; Sun CX; Zhu F; Glogauer M. 2005. The role of Rac1 and Rac2 in bacterial killing. Cell Immunol 235(2):92-7. [PubMed: 16157315] [MGI Ref ID J:107943]
Li B; Yu H; Zheng W; Voll R; Na S; Roberts AW; Williams DA; Davis RJ; Ghosh S; Flavell RA. 2000. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science 288(5474):2219-22. [PubMed: 10864872] [MGI Ref ID J:63080]
Li S; Yamauchi A; Marchal CC; Molitoris JK; Quilliam LA; Dinauer MC. 2002. Chemoattractant-stimulated rac activation in wild-type and rac2-deficient murine neutrophils: preferential activation of rac2 and rac2 gene dosage effect on neutrophil functions. J Immunol 169(9):5043-51. [PubMed: 12391220] [MGI Ref ID J:79793]
McCarty OJ; Larson MK; Auger JM; Kalia N; Atkinson BT; Pearce AC; Ruf S; Henderson RB; Tybulewicz VL; Machesky LM; Watson SP. 2005. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem 280(47):39474-84. [PubMed: 16195235] [MGI Ref ID J:104107]
Ojha N; Roy S; He G; Biswas S; Velayutham M; Khanna S; Kuppusamy P; Zweier JL; Sen CK. 2008. Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing. Free Radic Biol Med 44(4):682-91. [PubMed: 18068132] [MGI Ref ID J:131305]
Pestonjamasp KN; Forster C; Sun C; Gardiner EM; Bohl B; Weiner O; Bokoch GM; Glogauer M. 2006. Rac1 links leading edge and uropod events through Rho and myosin activation during chemotaxis. Blood 108(8):2814-20. [PubMed: 16809619] [MGI Ref ID J:139459]
Savina A; Peres A; Cebrian I; Carmo N; Moita C; Hacohen N; Moita LF; Amigorena S. 2009. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity 30(4):544-55. [PubMed: 19328020] [MGI Ref ID J:147980]
Shimomura Y; Ogawa A; Kawada M; Sugimoto K; Mizoguchi E; Shi HN; Pillai S; Bhan AK; Mizoguchi A. 2008. A unique B2 B cell subset in the intestine. J Exp Med 205(6):1343-55. [PubMed: 18519649] [MGI Ref ID J:137039]
Sun CX; Downey GP; Zhu F; Koh AL; Thang H; Glogauer M. 2004. Rac1 is the small GTPase responsible for regulating the neutrophil chemotaxis compass. Blood 104(12):3758-65. [PubMed: 15308574] [MGI Ref ID J:94828]
Tan BL; Yazicioglu MN; Ingram D; McCarthy J; Borneo J; Williams DA; Kapur R. 2003. Genetic evidence for convergence of c-Kit- and alpha4 integrin-mediated signals on class IA PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells. Blood 101(12):4725-32. [PubMed: 12560232] [MGI Ref ID J:109998]
Thomas EK; Cancelas JA; Chae HD; Cox AD; Keller PJ; Perrotti D; Neviani P; Druker BJ; Setchell KD; Zheng Y; Harris CE; Williams DA. 2007. Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell 12(5):467-78. [PubMed: 17996650] [MGI Ref ID J:127321]
Utomo A; Cullere X; Glogauer M; Swat W; Mayadas TN. 2006. Vav proteins in neutrophils are required for FcgammaR-mediated signaling to Rac GTPases and nicotinamide adenine dinucleotide phosphate oxidase component p40(phox). J Immunol 177(9):6388-97. [PubMed: 17056570] [MGI Ref ID J:140509]
Utomo A; Hirahashi J; Mekala D; Asano K; Glogauer M; Cullere X; Mayadas TN. 2008. Requirement for Vav proteins in post-recruitment neutrophil cytotoxicity in IgG but not complement C3-dependent injury. J Immunol 180(9):6279-87. [PubMed: 18424751] [MGI Ref ID J:134524]
Walmsley MJ; Ooi SK; Reynolds LF; Smith SH; Ruf S; Mathiot A; Vanes L; Williams DA; Cancro MP; Tybulewicz VL. 2003. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302(5644):459-62. [PubMed: 14564011] [MGI Ref ID J:86765]
Wang QQ; Li H; Oliver T; Glogauer M; Guo J; He YW. 2008. Integrin beta1 regulates phagosome maturation in macrophages through Rac expression. J Immunol 180(4):2419-28. [PubMed: 18250451] [MGI Ref ID J:131992]
Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M. 2008. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis. J Bone Miner Res 23(2):260-70. [PubMed: 17922611] [MGI Ref ID J:145675]
Wheeler AP; Wells CM; Smith SD; Vega FM; Henderson RB; Tybulewicz VL; Ridley AJ. 2006. Rac1 and Rac2 regulate macrophage morphology but are not essential for migration. J Cell Sci 119(Pt 13):2749-57. [PubMed: 16772332] [MGI Ref ID J:110344]
Yamauchi A; Marchal CC; Molitoris J; Pech N; Knaus U; Towe J; Atkinson SJ; Dinauer MC. 2005. Rac GTPase isoform-specific regulation of NADPH oxidase and chemotaxis in murine neutrophils in vivo. Role of the C-terminal polybasic domain. J Biol Chem 280(2):953-64. [PubMed: 15504745] [MGI Ref ID J:96141]
Yan J; Chen S; Zhang Y; Li X; Li Y; Wu X; Yuan J; Robling AG; Karpur R; Chan RJ; Yang FC. 2008. Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1. Hum Mol Genet 17(7):936-48. [PubMed: 18089636] [MGI Ref ID J:132466]
Yu H; Leitenberg D; Li B; Flavell RA. 2001. Deficiency of small GTPase Rac2 affects T cell activation. J Exp Med 194(7):915-26. [PubMed: 11581314] [MGI Ref ID J:119437]
Colony Maintenance
Breeding & Husbandry This strain originated on a B6;129 background and has been backcrossed for at least 17 generations (11/01) on the C57BL/6 background. Homozygous mice must be maintained under specific pathogen-free conditions. Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.